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In both multiple sclerosis and experimental autoimmune
encephalomyelitis (EAE), the C-C chemokine receptor 6 (CCR6)
is critical for pathogenic T helper 17 (Th17) cell migration to the
central nervous system (CNS). Whereas many cytokines and
their receptors are potently regulated via post-transcriptional
mechanisms in response to various stimuli, how CCR6 expression is post-transcriptionally regulated in Th17 cells is
unknown. Here, using RNA-binding protein HuR conditional
knock-out (KO) and wild-type (WT) mice, we present evidence
that HuR post-transcriptionally regulates CCR6 expression by
binding to and stabilizing Ccr6 mRNA and by promoting CCR6
translation. We also found that HuR down-regulates several
microRNA expressions, which could target the 3ⴕ-UTR of Ccr6
mRNA for decay. Accordingly, knock-out of HuR reduced CCR6
expression on Th17 cells and impaired their migration to CNS
compared with the response of WT Th17 cells and thereby ameliorated EAE. Together, these findings highlight how HuR contributes to Th17 cell-mediated autoimmune neuroinflammation and support the notion that targeting HuR might be a
potential therapeutic intervention for managing autoimmune
disorders of the CNS.
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immune encephalomyelitis (EAE) (1–5). The signature cytokine produced by Th17 cells, IL-17 (2, 6), has been found previously to be involved in host defense against bacterial infection
(7, 8). Expression of the C-C chemokine receptor 6 (CCR6) on
Th17 cells is required for migration of pathogenic Th17 cells to
sites of inflammation (9 –12). In the CNS of mice with EAE,
Th17 cells expressing CCR6 are attracted by the chemokine
ligand 20 (CCL20), which is constitutively secreted by choroid
plexus epithelial cells (12–14); accordingly, anti-CCL20 antibody treatment in vivo significantly suppressed pathogenic
CD4⫹ T cell accumulation and the development of EAE (15,
16). Signaling by CCL20 through CCR6 allows Th17 cells to
cross the epithelial barrier of the choroid plexus and enter the
cerebrospinal fluid. Thus, the initial trigger of inflammation is
induced by CCR6-dependent autoreactive Th17 cell infiltration
of the uninflamed CNS (12–14). In agreement with this notion,
CCR6⫺/⫺ mice are resistant to development of EAE (12). Moreover, CCR6-expressing Th17 cells are enriched in the cerebrospinal fluid of patients with early clinical symptoms of multiple
sclerosis (12, 17, 18). Therefore, further understanding the
mechanisms that underlie CCR6 expression in Th17 cells may
uncover novel therapeutic targets for treatment of Th17 cellmediated autoimmune diseases.
Differentiation of Th17 cells is induced by activation of naive
CD4⫹ T cells in the presence of a milieu of inflammatory cytokines. TGF-␤ and IL-6 potently induce naive CD4⫹ T cells to
differentiate into Th17 cells, which are reinforced by IL-23 (6,
19, 20). During cytokine-mediated Th17 cell differentiation, the
transcription factor STAT3 and two orphan nuclear receptors,
ROR␥t and ROR␣, function to regulate Th17 cell differentiation (21, 22). The transcriptional regulation of CCR6 gene
expression on Th17 cells is known to be regulated by TGF-␤
and to require ROR␥t and ROR␣ (11).
Despite recent progress in understanding the regulation and
function of CCR6 on Th17 cells, it is still unclear how CCR6
out; CCR6, C-C chemokine receptor 6; RIP, RNA immunoprecipitation;
CCL20, chemokine ligand 20; miRNA, microRNA; qRT-PCR, quantitative RTPCR; IP, immunoprecipitation.

Downloaded from http://www.jbc.org/ at Thomas Jefferson University on September 27, 2017

Jing Chen‡§¶1, Jennifer L. Martindale储2, Carole Cramer‡, Myriam Gorospe储2, Ulus Atasoy**, Paul D. Drew‡‡,
and Shiguang Yu§ §§3
From the ‡Arkansas Biosciences Institute, Department of Biological Sciences, Arkansas State University, Jonesboro, Arkansas
72467, the §Department of Neurology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, the ¶Department of
Veterinary Pathobiology, University of Missouri, Columbia, Missouri 65211, the 储Laboratory of Genetics, NIA-Intramural Research
Program, National Institutes of Health, Baltimore, Maryland 21224, the **Department of Molecular Microbiology and Immunology
and Department of Surgery, University of Missouri, Columbia, Missouri 65211, the ‡‡Department of Neurobiology and
Developmental Sciences, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, and the
§§
Arkansas Biosciences Institute, Arkansas State University, Jonesboro, Arkansas 72467

HuR regulates CCR6 expression on Th17 cells

Results
Th17 cells express high levels of HuR and CCR6
In previous studies, we demonstrated that in comparison
with WT Th17 cells, HuR conditional knock-out (HuR KO)
Th17 cells induced less severe EAE after transfer into naive
C57BL/6 mice (28), which indicated that HuR plays a role in the
initiation of EAE. When using Rag1⫺/⫺ mice as recipients, the
difference in induction of EAE between WT and HuR KO Th17
cells was much more significant, and the difference in EAE
severity between the two groups lasted for 3 weeks, at which
time the experiment was ended (data not shown). Because
recipients that received HuR KO Th17 cells had fewer CD4⫹ T
cell infiltrations in the CNS (28), we speculated that HuR KO
Th17 cells may exhibit impaired migration into the inflamed
CNS. Because CCR6 is crucial for the pathogenic Th17 cell
migration in rheumatoid arthritis and EAE (10, 12, 29), we
sought to investigate whether HuR regulates expression of
CCR6 on Th17 cells.
Our previous studies showed that naive CD4⫹ T cells
expressed low levels of HuR protein, and activation of CD4⫹ T
cells by anti-CD3 plus anti-CD28 increased expression of HuR
(28). Further analysis showed that anti-CD3 alone induced an
intermediate level of HuR protein expression, and anti-CD28 or
IL-2 synergized with anti-CD3 to induce a high level of HuR

protein expression (data not shown). These findings supported
the idea that HuR may play an important role in T cell activation, in agreement with our previous studies (30). To determine
whether there is a relationship between expression of CCR6
and HuR protein in T helper cells, naive CD4⫹ T cells from WT
mice were isolated and cultured under different T helper cell or
T regulatory (Treg) cell polarization conditions. The expression levels of CCR6 and HuR on Th1, Th2, Th17, and Treg cells
were measured by qRT-PCR, flow cytometry, and Western blot
analysis, respectively. As shown, CCR6 was highly expressed on
Th17 cells, modestly expressed on Treg cells, and expressed at
low levels on Th1 and Th2 cells, and the level of Ccr6 mRNA
expression correlates well with level of CCR6 protein expression in these different Th subsets (Fig. 1, A and B). Western blot
analysis demonstrated a similar pattern of HuR expression in
these T subset cells, with the highest expression of HuR in Th17
cells, moderate HuR levels in Treg cells, and lowest expression
in Th1 cells (Fig. 1C). Furthermore, differentiation of Th17 cells
resulted in an average 2-fold increase in HuR protein expression levels in comparison with CD4⫹ T cells activated with
anti-CD3 plus anti-CD28 and without Th17 cell polarization
cytokines (Fig. 1, C and D). Together, these findings suggest
that the expression of CCR6 correlates with the level of HuR
protein in Th17 cells, supporting our hypothesis that HuR positively promotes expression of CCR6 in Th17 cells.
HuR deficiency reduces the expression of Ccr6 mRNA and
protein levels in Th17 cells
We utilized HuR conditional knock-out mice to more definitively evaluate the relationship between HuR and CCR6
expression in Th17 cells. We isolated naive CD4⫹ T cells from
spleens of WT and HuR KO mice and cultured the cells under
Th17 cell polarization conditions (28). Reverse transcription
followed by qRT-PCR revealed that expression of Ccr6 mRNA,
but not il22 mRNA, was significantly reduced in HuR KO Th17
cells in comparison with WT Th17 cells (Fig. 2A). Consistent
with the qRT-PCR data, Western blot and flow cytometric analyses revealed that the level of CCR6 protein was also decreased
in HuR KO Th17 cells compared with WT Th17 cells (Fig. 2,
B–F). These results further supported the notion that HuR positively regulates CCR6 expression on Th17 cells.
Computational analysis showed that mouse Ccr6 mRNA
with short 3⬘-UTR contains one potential HuR binding site.
However, the human CCR6 mRNA contains several HuR
potential binding sites in the ORF and the 3⬘-UTR (data not
shown). Thus, we hypothesized that HuR may also regulate
CCR6 expression on human CD4⫹ T cells, which might have
clinically relevant consequences, given the identification of
CCR6-positive Th17 cells in multiple sclerosis (17). To test this
possibility, naive CD4⫹ T cells were isolated from human
peripheral blood, and HuR expression was reduced by transfection with siRNA directed at the HuR mRNA. The cells were
differentiated using Th17 cell culture conditions (28). The
results revealed that CCR6 expression was reduced following
knockdown of HuR in human CD4⫹ T cells compared with
cells treated with scrambled control siRNA (Fig. 2, G–I), suggesting that HuR may play a similar role in controlling CCR6
expression on human CD4⫹ T cells.
J. Biol. Chem. (2017) 292(35) 14532–14543
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expression is post-transcriptionally regulated. Given the
importance of post-transcriptional gene regulation in eliciting
quick responses to stimuli, defining the mechanisms mediating
post-transcriptional regulation is a very active area of research
(23, 24). Mammalian HuR is the homolog of the ELAV (embryonic lethal abnormal vision)-like protein in Drosophila melanogaster (25) and is ubiquitously expressed in all tissues. HuR
binds to target mRNAs bearing specific sequence elements,
often U- and AU-rich and generally found in the mRNA
3⬘-UTRs, and plays a critical role in their post-transcriptional
regulation (26). HuR stabilizes many target mRNAs encoding
proteins with roles in cell proliferation, survival, immune
responses, and differentiation (27). Although HuR is known to
stabilize many of these mRNAs and/or modulate their translation, the molecular mechanisms by which HuR affects the fate
of target mRNA remain unknown. In addition, recent studies
indicate that HuR may mediate some of its effects through
interplay with microRNAs (miRNAs) associated with the same
target mRNAs (27).
In this study, we focused on investigating the role of HuR in
mediating expression of CCR6 on pathogenic Th17 cells in
EAE. HuR binds to Ccr6 mRNA to prolong its half-life and
moderately increases its translation, leading to increased CCR6
expression. In addition, our data indicate that HuR negatively
regulates the expression of some miRNAs, and thus HuR may
prevent these miRNAs from binding to and degrading Ccr6
mRNA, further enhancing CCR6 expression. Knock-out of
HuR decreases CCR6 expression on Th17 cells and impairs
their migration in response to its ligand, CCL20, thereby ameliorating EAE. These results further support the notion that
targeting HuR might be a novel therapeutic intervention for
autoimmune encephalomyelitis (28).

HuR regulates CCR6 expression on Th17 cells

Because macrophages treated with LPS express high levels of
CCR6 (31, 32), we evaluated whether knockdown of HuR
altered CCR6 expression on macrophages. The results shows
that silencing HuR significantly reduced the expression of HuR
in RAW 264.7 macrophages (data not shown). Flow cytometric
analysis revealed that HuR silencing also selectively decreased
CCR6 expression on macrophages (data not shown). These
data further support the notion that HuR positively regulates
CCR6 expression.
HuR modulates CCR6 expression by binding to and stabilizing
Ccr6 mRNA
HuR has three RNA recognition motifs through which it
interacts with target mRNAs (26). To explore the mechanism
underlying the regulation of CCR6 expression by HuR, we performed an RNA immunoprecipitation (RIP) assay to examine
whether HuR proteins physically associate with Ccr6 mRNA.
Following RIP using anti-HuR antibody (3A2) beads in Th17
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cell lysates, the RNA was isolated from the immunoprecipitated
material, reverse transcribed, and quantitated by qRT-PCR
analysis. Control immunoprecipitation (IP) reactions were carried out in parallel using an IgG. As shown in Fig. 3A, Ccr6
mRNA was significantly enriched in anti-HuR IP samples compared with isotype-matched IgG controls, after normalization
of RNA levels in all IP samples by amplifying a Gapdh mRNA,
which encodes a housekeeping protein and is not a target of
HuR. These findings indicate that HuR forms a complex with
Ccr6 mRNA.
HuR regulates many target mRNAs by modulating their stability and/or translation rate (27). To determine whether HuR functions to protect Ccr6 mRNA from degradation, we isolated naive
CD4⫹ T cells from WT and KO mice and cultured them under
Th17 polarization conditions. The polarized Th17 cells were
treated with the RNA polymerase II inhibitor actinomycin D to
inhibit de novo transcription, and the Ccr6 mRNA decay rates
were measured by qRT-PCR analysis. As indicated in Fig. 3B, the
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Figure 1. Expression of CCR6 and HuR on T helper cells and Treg cells. Naive CD4⫹ T cells were isolated from spleen of WT mice and activated or
polarized as described under “Experimental procedures.” Activation (Act), Th1, Th2, Th17, and Treg cells were analyzed after 5 days of cell culture.
Expressions of CCR6 on T helper cells and Treg cells were analyzed by flow cytometry (A) and qRT-PCR (B). C, HuR protein levels in CD4⫹ T cells were
assessed by Western blot analysis. D, summary of HuR protein level in Th17 cells compared with that of activated CD4⫹ T cells. One of three independent
experiments is shown in A and C. Data in B and D are derived from at least three independent experiments and presented as mean ⫾ S.E. (error bars). *,
p ⬍ 0.05; **, p ⬍ 0.01.

HuR regulates CCR6 expression on Th17 cells
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Figure 2. Knock-out of HuR reduces CCR6 expression on Th17 cells. Naive CD4⫹ T cells were isolated from spleen of WT and HuR KO mice and cultured
under Th17 cell–polarizing conditions for 5 days. A, Ccr6 mRNA levels were measured by qRT-PCR analysis. B, Western blot analysis of CCR6 expression
on WT and HuR KO Th17 cells. C and D, flow cytometric analysis of CCR6 expression on Th17 cells. E, summary of flow cytometric analysis of three
independent experiments. F, the percentage of CCR6⫹IL-17⫹ cells was reduced in HuR KO Th17 cells compared with that of WT Th17 cells. G, human
peripheral blood CD4⫹ T cells were isolated and transfected with scrambled and HuR siRNA and cultured in the presence (Th17) or absence (Act) of Th17
cell–polarizing cytokines. HuR protein expression levels were then assessed by Western blot analysis. H, qRT-PCR analysis of Ccr6 mRNA levels following
transfection of human Th17 cells with scramble and HuR siRNAs (SiHuR). I, the level of CCR6 protein was also reduced in HuR siRNA-transfected human
Th17 cells compared with that with scramble siRNA by Western blots. Data in B–D, F, and I represent one of three independent experiments. Data in G
represent one of three independent experiments. Data in A, E, and H are summarized at least three independent experiments and are presented as
mean ⫾ S.E. (error bars). *, p ⬍ 0.05; **, p ⬍ 0.01; ***, p ⬍ 0.001.

J. Biol. Chem. (2017) 292(35) 14532–14543
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Figure 3. HuR binds to and stabilizes Ccr6 mRNA. Naive CD4⫹ T cells were isolated from spleens of WT mice and stimulated under Th17 cell–polarizing
conditions. A, RIP analysis was performed to detect Ccr6 mRNA enrichment after IP using anti-HuR (3A2) or isotype-matched antibody (IgG1) from Th17
cell cytoplasmic extracts. Il23r mRNA was assayed as negative control. B, WT and HuR KO Th17 polarized cells were either left untreated or treated with
actinomycin D (Act D; 3 g/ml) and harvested 1, 3, and 5 h later. Ccr6 mRNA levels were determined by qRT-PCR analysis. C, WT and HuR KO Th17 cell
lysates were size-fractionated through sucrose gradients, and RNA was isolated from each of 12 fractions, reverse-transcribed, and measured by
qRT-PCR analysis. The relative distribution of Ccr6 mRNA along the gradient was calculated and plotted as a percentage of the total Ccr6 mRNA in the
gradient. D, the distribution of actin mRNA, encoding a housekeeping protein, was included as a negative control. E, overexpression of HuR by HuR
plasmid (0.2 g) transfection increased the luciferase activity of vector containing Ccr6 mRNA ORF and 3⬘-UTR (0.2 g) in HeLa cells in comparison with
empty vector control groups. One of three independent experiments is shown in A–D. Data in E represent one of two individual experiments. **, p ⬍ 0.01;
***, p ⬍ 0.001; NS, not significant. Error bars, S.E.

half-life of Ccr6 mRNA in HuR KO Th17 cells was much shorter
than that in WT Th17 cells (1.91 h versus 3.41 h), suggesting that
HuR binds to and stabilizes Ccr6 mRNA to prolong its half-life.
We then asked whether HuR functions to modulate Ccr6
mRNA translation. Polysome fractionation analysis is useful to
analyze the RNA-binding protein regulation of target mRNA
translation (33). We compared the relative sizes of Ccr6 mRNA
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associated with polyribosomes in WT and HuR KO Th17 polarized cells. Following fractionation through sucrose gradients,
Ccr6 mRNA polyribosomes in HuR KO Th17 cells showed
moderately smaller size (shifted toward polysomes of lower
molecular weight) compared with those in WT Th17 cells (Fig.
3C). By contrast, actin mRNA, encoding a housekeeping protein,
did not show this shift in distribution toward smaller molecular

HuR regulates CCR6 expression on Th17 cells

weight (Fig. 3D). These findings suggested that in addition to promoting the stability of Ccr6 mRNA, HuR also moderately promoted Ccr6 mRNA translation. Indeed, overexpression of HuR by
HuR plasmid transfection increases the luciferase activity of vector
containing Ccr6 mRNA ORF and 3⬘-UTR in HeLa cells compared
with the control group (Fig. 3E).
miRNA-mediated Ccr6 mRNA decay
Besides RNA-binding proteins, microRNAs also regulate
gene expression in a sequence-specific manner, often through
interplay with RNA-binding proteins that associate with the
same mRNAs (34). The physical and functional interaction of

HuR with miRNAs has been documented (27). To investigate
the possibility that HuR affects the fate of Ccr6 mRNA via
miRNAs, computational analyses were performed using the
TargetScan and miRanda algorithms to identify potential
miRNA binding sites in the Ccr6 3⬘-UTR. Three sites were
identified: miR-409, miR-197, and miR-335 (Fig. 4A). To determine whether there was any functional link between HuR and
miRNAs predicted to bind the Ccr6 3⬘-UTR, qRT-PCR analysis
was performed to detect these miRNAs in WT and HuR KO
Th17 cells. Interestingly, whereas miR-155 levels were unchanged
in the two Th17 populations, miR-409 and miR-335 levels were
increased 2–3-fold (Fig. 4B), and miR-197 level increased 1.5J. Biol. Chem. (2017) 292(35) 14532–14543
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Figure 4. MiR-335 negatively regulates Ccr6 mRNA. A, TargetScan analysis prediction that miR-335, miR-197, and miR-409 have potential binding sites on
the CCR6 3⬘-UTR. B, qRT-PCR analysis shows that knock-out of HuR increased the level of miR-335 and miR-409 in Th17 cells. C, overexpression of miR-335
reduced the activity of luciferase reporter containing the CCR6 3⬘-UTR. HeLa cells were transfected with a luciferase reporter construct containing CCR6 3⬘-UTR,
in which overexpression of miR-335 decreased the luciferase activity. Data in B and C were derived from at least three independent experiments. D, sketch
diagram of a luciferase reporter construct containing CCR6 3⬘-UTR. *, p ⬍ 0.05; **, p ⬍ 0.01. Error bars, S.E.

HuR regulates CCR6 expression on Th17 cells

fold (data not shown) in HuR KO Th17 cells compared with
WT Th17 cells, suggesting that HuR may negatively impact the
levels of certain miRNAs.
Because miRNAs robustly regulate gene expression by degrading and/or repressing the translation of target mRNAs (34), we
investigated whether miR-409 and miR-335 bind to their predicted sites of Ccr6 mRNA 3⬘-UTR and regulate its expression. A
reporter vector expressing firefly luciferase from a transcript that
contained the Ccr6 3⬘-UTR (Fig. 4D) was cotransfected with
miRNA mimics into HeLa cells. Analysis of luciferase activity in
HeLa cells revealed that overexpression of miR-335 reduced the
luciferase activity of the reporter construct, whereas overexpression of control scrambled miRNAs did not (Fig. 4C), suggesting
that miR-335 was capable of selectively degrading Ccr6 mRNA.
Similarly, overexpression of miR-409 in HeLa cells elicited a similar reduction in reporter luciferase activity (data not shown).
Genetic ablation of HuR impairs Th17 cell migration in
response to CCL20 in vitro and in vivo
CCR6 is critical for Th17 cell migration to sites of inflammation (10, 12, 29, 35, 36). The lack of CCR6 on Th17 cells in mice
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decreases their susceptibility to autoimmune diseases, including EAE (12, 29, 35, 36). To evaluate the function of HuR in
Th17 cell migration, we used a 24-well plate carrying a transwell-permeable membrane to compare the capacity of WT
with HuR KO Th17 cells to migrate toward the chamber containing CCL20, as previously described (11). WT and HuR KO
Th17 cells were cultured in the upper well in transmembrane
plates, and CCL20 was added to the lower chamber. As shown
in Fig. 5A, a large number of WT Th17 cells migrated into the
lower chamber in response to CCL20. In contrast, HuR KO
Th17 cell migration was significantly decreased, indicating that
knock-out of HuR in Th17 cells, where CCR6 expression was
impaired, resulted in decreased Th17 cell migration, which
is consistent with the in vivo findings that fewer CD4⫹ T cells
were present in the CNS of recipients of HuR KO Th17 cells
(28).
Consistent with this experiment in cultured cells, ex vivo
experiments revealed that expression of Ccr6 mRNA in splenic
CD4⫹ T cells was significantly reduced in HuR KO mice compared with that of WT mice with EAE (Fig. 5B), suggesting that
HuR may also promote expression of CCR6 by inflammatory
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Figure 5. Knock-out of HuR impairs Th17 cell migration in vitro and in vivo. A, Transwell chemotaxis assay of WT and HuR KO Th17 cells was performed in the
presence of CCL20 (CCR6 ligand). The migrated cells were analyzed at 3 h of culture. HuR deficiency significantly reduced Th17 cell migration to CCL20. B, CCR6 mRNA
level in splenic CD4⫹ T cells from WT and HuR KO and mice with EAE. C, number of CD4⫹CCR6⫹ cells in the CNS of WT and HuR KO mice with EAE measured by flow
cytometric analysis. D, CCR6 expression on CNS monocytes from recipients of WT and HuR KO Th17 cells. The results shown in A–D are a summary of at least three
independent experiments. All data are expressed as the mean ⫾ S.E. (error bars). *, p ⬍ 0.05; **, p ⬍ 0.01.

HuR regulates CCR6 expression on Th17 cells

cells in vivo. Indeed, flow cytometric analysis revealed that the
number of inflammatory CD4⫹CCR6⫹ cells was significantly
reduced in the CNS of HuR KO mice relative to WT mice with
EAE (Fig. 5C). Furthermore, Ccr6 mRNA was much lower in
CNS monocytes from mice that received HuR KO Th17 cells
than mice receiving WT Th17 cells (Fig. 5D).
HuR regulates CCR6 expression on Th17 cells for promoting
the initiation of EAE
We previously demonstrated that transfer of HuR⫺/⫺ Th17
cells induced less severe EAE in naive C57BL/6 recipients compared with that of WT Th17 cells (28). However, in active EAE,
the clinical score in HuR KO mice is only slightly less severe
than that of WT mice at early stages of immunization (days 5 to
10), and the disease severity in both groups is similar at the late
stages of induction (Fig. 6A). It is well known that Treg cells play
an important role in the resolution of EAE (37–39). Because
CCR6 is also expressed on Treg cells, we hypothesized that
knock-out of HuR reduces the expression of CCR6 on Treg
cells, resulting in fewer Treg cells migrating into the CNS and
less suppression of EAE pathogenesis. To test this hypothesis,
WT and HuR KO Treg cells were generated from naive CD4⫹ T
cells under Treg cell culture conditions. The levels of Ccr6

mRNA (Fig. 6B) and protein (Fig. 6, C and D) in HuR KO Treg
cells were drastically lower than those in WT Treg cells. To
exclude the effect of HuR on Treg cells and to better understand
the function of HuR in Th17 cells, we depleted Treg cells by
injection of anti-CD25 (PC61) 10 days before induction of EAE
in WT and HuR KO mice. This treatment regimen was chosen
given our previous findings that one injection of anti-CD25 was
able to transiently deplete most Treg cells in the spleen and
lymph nodes (40, 41). In addition, anti-CD25 antibody was
degraded 10 –14 days later, which would not deplete the effector T cells when mice are immunized for induction of EAE. The
results showed that when Treg cells were transiently depleted,
HuR KO mice developed significantly less severe EAE than did
WT mice (Fig. 6E), which further demonstrated that knock-out
of HuR reduces CCR6 expression on Th17 cells, leading to
impaired initiation of EAE.

Discussion
In this study, we have demonstrated that HuR post-transcriptionally regulates CCR6 expression on Th17 cells. Mechanistically, HuR binds to Ccr6 mRNA to promote its stability and
prolong its half-life. HuR deficiency reduces Ccr6 mRNA and
J. Biol. Chem. (2017) 292(35) 14532–14543
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Figure 6. After Treg cell depletion, the severity of EAE is lower in HuR KO than in WT mice. A, EAE in WT and HuR KO mice without Treg cell depletion. Each group
contains six mice. CCR6 levels on WT and HuR KO Treg cells were analyzed by qRT-PCR (B), Western blots (C), and flow cytometry (D). E, EAE in WT and HuR KO mice in
which Treg cells were depleted by anti-CD25 10 days earlier. Each group contains 11 mice. One of two representative experiments is shown in A, C, D, and E. Data in B
are derived from at least three independent experiments and presented as mean ⫾ S.E. (error bars). *, p ⬍ 0.05; **, p ⬍ 0.01.
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the activity of vectors containing the Ccr6 3⬘-UTR. Interestingly, knock-out of HuR in CD4⫹ T cells increased the expression of these miRNAs, indicating that HuR may negatively regulate their expression. Additional studies are needed to define
the underlying mechanism by which HuR inhibits the expression of certain miRNAs. One possible explanation is that HuR
cooperates with the miRNA let-7 in down-regulating the
expression of c-Myc (48, 49), a transcription factor that promotes microRNA biogenesis (50), and thus knock-out of HuR
may increase c-Myc expression, which, in turn, promotes
expression of microRNAs. This possibility remains to be tested
experimentally.
Our previous work showed that HuR KO Th17 cells are less
pathogenic than WT Th17 cells for inducing EAE (28). Our
current study revealed that HuR deficiency reduces CCR6
expression in Th17 cells and impairs their migration in
response to its ligand CCL20. This finding is consistent with
our previous report that fewer CD4⫹ T cells migrated into the
CNS in mice receiving HuR KO Th17 cells compared with
those transferred with WT Th17 cells (28). In addition, early
reports showed that CCR6-deficient autoreactive Th17 cells
failed to migrate to the CNS, which resulted in the development
of less severe EAE (12).
Because CCR6 is also expressed on Treg cells (11), knock-out
of HuR also reduced CCR6 expression in Treg cells (Fig. 6),
resulting in reduced Treg cell migration to the CNS, which
might account for the moderate difference in severity at early
stages between WT and HuR KO mice in actively induced EAE.
To test this possibility, we depleted Treg cells by anti-CD25 in
WT and HuR KO mice before the induction of the disease. As
expected, Treg cell-depleted HuR KO mice develop significantly less severe EAE than do WT mice (Fig. 6E), supporting
the idea that knock-out of HuR dampens the pathogenicity of
Th17 cells for induction of EAE. Taken together, our results
suggest that HuR modulates CCR6 expression on Th17 cells to
contribute to autoimmune neuroinflammation.

Experimental procedures
Animals
HuRflox/flox mice were generated as described previously (28,
51). 8 –10-week-old control (HuRflox/flox) mice and HuR KO
mice (OX40-cre HuRflox/flox) were used. All mice were on the
C57BL/6 background and were bred at the animal facility of
Arkansas Bioscience Institute at Arkansas State University
and/or the Thomas Jefferson University. Animal experiments
were approved by the institutional animal care and use committee and performed according to federal and institutional
guidelines.
Isolation and differentiation of CD4ⴙ T cells in vitro
Naive CD4⫹ T cells were purified from splenocytes using
CD4 negative selection kits (catalog no. 19852A, StemCell
Technologies, Vancouver, Canada) following the manufacturer’s protocol. Single splenocytes were prepared by using a
70-m nylon mesh cell strainer (catalog no. 22363548, Fisher)
and incubated with mouse CD4⫹ T cell isolation mixture (catalog no. 19852c.1, StemCell Technologies) followed by adding
Straptavidin RapidSpheres (catalog no. 50001, StemCell Tech-
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protein levels, leading to reduced Th17 cell migration, in turn
impairing the initiation of EAE.
Animal model studies showed that CCR6 is essential for
development of autoimmune diseases, and Ccr6⫺/⫺ mice are
resistant to EAE, rheumatoid arthritis, and atherosclerosis (10,
12, 29, 35, 36). Clinical studies showed that CCR6 is expressed
at significantly higher levels in lesions of psoriatic skin than in
normal skin (42). CCR6 was identified as a risk factor for rheumatoid arthritis. Moreover, a nucleotide polymorphism within
the CCR6 locus was shown to be associated with susceptibility
to rheumatoid arthritis, Graves’ disease, and Crohn’s disease
(43, 44). Mechanistic studies further demonstrated that CCR6
is required for pathogenic Th17 cell migration to inflamed tissues (9, 10, 29). More specifically, CCR6-positive Th17 cells
cross the blood– brain barrier through the interaction between
CCR6 and its ligand CCL20 in choroid plexus to induce EAE
and multiple sclerosis (12). Therefore, further understanding
the regulation of CCR6 expression may provide a novel venue
for drug design to treat autoimmune inflammation.
Previous studies indicated that TGF-␤ promotes CCR6
expression on Th17 cells through transcription factors ROR␥t
and ROR␣ (11). Further studies identified a noncoding region
of the human CCR6 gene with methylation-sensitive transcriptional activity in CCR6⫹ T cells that controls stable CCR6
expression via epigenetic mechanisms (43). However, the posttranscriptional modulation of CCR6 expression is unknown.
Understanding this process is important because post-transcriptional gene regulation permits 1) synthesis of protein by
translation from mRNA stored in cytoplasmic granules more
rapidly than from newly synthesized transcripts, 2) metabolic
economy, because translational repression allows the rapid
turning off of protein production while preserving the mRNA,
which allows reinitiation at a later time if conditions warrant it,
and 3) sensitivity to environmental stimuli via receptors on the
cell surface linked to signaling pathways that regulate the translation and decay of mRNA (24). Thus, we studied how CCR6
expression is post-transcriptionally regulated by RNA-binding
protein HuR. Interestingly, compared with Th1 and Th2 cells,
Th17 cells express the highest level of HuR, and Treg cells
express moderate levels of HuR (Fig. 1), consistent with previous reports that SMAD transcriptionally activates HuR expression (45) and that TGF-␤ required for Th17 and Treg cell differentiation is able to activate SMAD (6, 46, 47).
We previously showed that knock-out of HuR in Th17 cells
reduces IL-17 mRNA stability (28). We now provide evidence
that Ccr6 mRNA is enriched in anti-HuR IP complexes, indicating that HuR protein interacts with Ccr6 mRNA. In addition,
we demonstrate that HuR⫺/⫺ CD4⫹ T cells display reduced
Ccr6 mRNA half-life when cells are polarized under Th17 cell
culture conditions (Fig. 3). Although HuR binds to and stabilizes Ccr6 mRNA to promote its expression, we could not
exclude the possibility of HuR modulating transcription factors
to modulate CCR6 expression in Th17 cells. Work is in progress
to address this possibility.
RNA-binding proteins can coordinate with miRNAs to regulate target gene expression post-transcriptionally (34). Several
miRNAs like miR-335 and miR-409 are expressed in Th17 cells.
Reporter analyses revealed that miR-335 and miR-409 reduced
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Table 1
Sequences of mouse quantitative RT-PCR primers

Table 3
Sequences of human quantitative RT-PCR primers

Primers

Sequences

Primers

Sequences

CCR6 forward
CCR6 reverse
HuR forward
HuR reverse
IL-23R forward
IL-23R reverse
IL-17A forward
IL-17A reverse
GAPDH forward
GAPDH reverse
IL-22 forward
IL-22 reverse
␤-Actin forward
␤-Actin reverse

5⬘-CCTCACATTCTTAGGACTGGAGC-3⬘
5⬘-GGCAATCAGAGCTCTCGGA-3⬘
5⬘-ACTGCAGGGATGACATTGGGAGAA-3⬘
5⬘-AAGCTTTGCAGATTCAACCTCGCC-3⬘
5⬘-TTCAGATGGGCATGAATGTTTCT-3⬘
5⬘-CCAAATCCGAGCTGTTGTTCTAT-3⬘
5⬘-TGTGTCTCTGATGCTGTTGCTGCT-3⬘
5⬘-AGGAAGTCCTTGGCCTCAGTGTTT-3⬘
5⬘-TCAACAGCAACTCCCACTCTTCCA-3⬘
5⬘-ACCCTGTTGCTGTAGCCGTATTCA-3⬘
5⬘-TTGAGGTGTCCAACTTCCAGCA-3⬘
5⬘-AGCCGGACGTCTGTGTTGTTA-3⬘
5⬘-GGCTGTATTCCCCTCCATCG-3⬘
5⬘-CCAGTTGGTAACAATGCCATGT-3⬘

CCR6 forward
CCR6 reverse
HuR forward
HuR reverse
IL-23R forward
IL-23R reverse
GAPDH forward
GAPDH reverse

5⬘-TGAGCGGGGAATCAATGAATT-3⬘
5⬘-TCCTGCAAGGAGCACAGTAACA-3⬘
5⬘-AACTACGTGACCGCGAAGG-3⬘
5⬘-CGCCCAAACCGAGAGAACA-3⬘
5⬘-ACATGCTTCTATGTACTGCACTG-3⬘
5⬘-TGTGTCTATGTAGGTGAGCTTCC-3⬘
5⬘-GGAGCGAGATCCCTCCAAAAT-3⬘
5⬘-GGCTGTTGTCATACTTCTCATGG-3⬘

Table 2
Sequences of siRNA for human T cell transfection
Sequences
5 ⬘-GAGUGAAGGAGUUGAAACUTT-3⬘
5⬘-GCCAAUUCAUCAGCAAUGGTT-3⬘

nologies), placing the tube containing the splenocytes into a
magnet for 3 min and pouring the unlabeled CD4⫹ T cells into
a new tube. The isolated CD4⫹ T cells were cultured as
described previously (28, 52). Purified naive CD4⫹ T Cells were
activated with plate-bound anti-CD3 (10 g/ml) (14-0032,
eBioscience (San Diego, CA)) and anti-CD28 (3 g/ml) (140281, eBioscience). For Th1 polarization, IL-12 (10 ng/ml)
(419-ML-010, R&D Systems (Minneapolis, MN)) and anti-IL-4
(10 g/ml) (16-7041, eBioscience) were additionally used. For
Th17 polarization, TGF-␤ (3 ng/ml) (rH100-21, PeproTech),
IL-6 (20 ng/ml) (9216-6, PeproTech), IL-23 (20 ng/ml) (148231, eBioscience), anti-IFN-␥ (10 g/ml) (16-7312, eBioscience), and anti-IL-4 (10 g/ml) were additionally used. For Th2
cell polarization, IL-4 (10 g/ml), IL-2 (10 ng/ml) (212-12, PeproTech), and anti-IFN-␥ (10 g/ml) were added. For Treg cell
polarization, TGF-␤ (5 ng/ml), IL-2 (10 ng/ml), anti-IFN-␥ (10
g/ml), and anti-IL-4 (10 g/ml) were additionally used. All
cytokines were purchased from R&D Systems and PeproTech
(Rocky Hill, NJ), and antibodies were purchased from
eBioscience.
RNA isolation and qRT-PCR
Cells were collected, and total RNA was extracted using TRIzol (Invitrogen). 500 ng of RNA was reverse-transcribed into
cDNA using the SuperScript III kit (Invitrogen) according to
the manufacturer’s protocols. The cDNA was subjected
to quantitative real-time PCR analysis using the CFX96 realtime PCR detection system (Bio-Rad) with SYBR Green reagent
kit (Invitrogen) according to the manufacturer’s protocols. The
Cq data of test mRNAs were normalized to the data of Gapdh
mRNA for each sample, and the gene expression of WT was
designated as 1. The gene expression in the KO group was relative
to those of WT (28). Forward and reverse primers for specific
murine target genes are listed in Table 1. Sequences of HuR siRNA
and scrambled siRNA are listed in Table 2. Forward and reverse
primers for human target genes are listed in Table 3.

The migration assay was performed in 24-well plates (Costar,
Corning, NY) carrying Transwell-permeable supports with a
5-m polycarbonate membrane for T cells. Briefly, 5 ⫻ 105
polarized Th17 cells were added to the upper wells in 200 l of
culture medium, and the recombinant CCL20 (250-27, PeproTech) was added to the lower chambers in 600 l of culture
medium. Cells were cultured for 3 h, and cell migration was
determined by counting the number of T cells in the lower
chambers.
Transient depletion of Treg cells and EAE induction
To deplete Treg cells, anti-CD25 antibody (0.5 mg/mouse)
(PC61, BioXcell) was injected i.p. 10 days before EAE induction.
For induction of active EAE, 8 –10-week-old female WT
mice and HuR conditional KO mice were immunized with
MOG(35–55) and complete Freund’s adjuvant followed by
injection of pertussis toxin. EAE was clinically assessed by daily
assignment of scores on a scale of 0 –5 as described previously
(28).
Isolation of mononuclear cells from CNS
Mononuclear cells were extracted from inflamed CNS tissue
of EAE mice as described previously (28, 52). Briefly, mice were
perfused with cold PBS to remove blood from internal
organs. The spinal cord was flushed out by hydrostatic pressure. Brain and spinal cords were digested in a solution with
0.2 units/ml Liberase DL (Roche Applied Science) and 1
mg/ml DNase I (Roche Applied Science) in DMEM at 37 °C
for 45 min. A single-cell suspension was prepared by passing
through a 70-m cell strainer, followed by centrifugation
through a Percoll gradient (37%/70%). Mononuclear cells in
the interphase layer were transferred into a fresh tube and
used in subsequent experiments for RNA isolation and for
flow cytometry analysis.
Western blotting
Whole-cell lysates were prepared in RIP buffer (catalog no.
89900, Thermo Scientific), and Western blot analysis was performed as described previously (28, 52). The concentration of
protein was determined with BCA protein assay reagent
(Thermo Scientific). Protein samples were separated by 10%
SDS-PAGE and transferred to a nitrocellulose membrane (BioRad). The membranes were incubated with primary antibodies
recognizing HuR (Sc-5261, Santa Cruz Biotechnology, Inc.,
Dallas, TX), ␤-actin (Sc-130657, Santa Cruz Biotechnology), or
CCR6 (NBP2-25220, Novus Biologicals) followed by incubation
with goat anti-mouse or goat anti-rat secondary Ig conjugated
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siRNAs
HuR siRNA
Scramble siRNA

In vitro migration assay
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with HRP (Jackson ImmunoResearch Laboratories Inc., West
Grove, PA). Membranes were developed by SuperSignal West
Pico chemiluminescent substrate (Thermo Scientific).
Flow cytometry
Cells obtained from in vitro and ex vivo culture were stained
for surface markers with allophycocyanin-conjugated antiCD4 and phycoerythrin-conjugated anti-CCR6 (129804, Biolegend, San Diego, CA). Acquisitions were made with a BD
FACSCalibur (BD Biosciences). Cell Quest software was used
for data analysis.
Immunoprecipitation of endogenous messenger
ribonucleoprotein complexes

Transfection and luciferase assay
HeLa cells (CCL-2, ATCC) were cultured in DMEM containing 10% FBS, penicillin (100 units/ml), streptomycin (100
g/ml), 2 mM L-glutamine, and non-essential amino acids
(Invitrogen). A total of 2 ⫻ 105 cells in 1 ml of cell culture
medium were seeded into each well of 24-well plates and incubated overnight. Transient transfections were performed using
Lipofectamine 2000 (Invitrogen) with 0.3 g of firefly luciferase
plasmid DNA (GeneCopoeia, Rockville, MD) and 0.15 g of
pRL-CMV-renilla-luciferase plasmid. Cells were co-transfected with 40 – 80 nmol of miRNA (Life Sciences). 24 h later,
cells were collected, and luciferase activities were measured
using a Dual-Luciferase reporter assay system according to the
manufacturer’s instructions (Promega, Madison, WI). Firefly
luciferase activity was normalized to Renilla luciferase in the
same transfection groups.
Statistical analysis
Student’s t test was used to analyze the differences between two
groups for the experiments. The data are expressed as the mean ⫾
S.E. A p value ⬍ 0.05 was considered statistically significant.
Author contributions—J. C. and S. Y. designed and performed most
of the experiments; J. L. M. did the polysome assay; C. C., M. G.,
U. A., P. D. D., and S. Y. analyzed the data; J. C., P. D. D., M. G., and
S. Y. wrote the manuscript. All authors reviewed the results and
approved the final version of manuscript.
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RIP was performed according to the established protocols
(28, 53). Briefly, Th17 polarized cells were lysed using polysome
lysis buffer (28). The lysates were precleared for 30 min at 4 °C
by adding 30 g of IgG1 (BD Biosciences) and 50 l of Protein
A–Sepharose beads (P3391, Sigma-Aldrich) swollen in NT2
buffer with 5% BSA (27, 30). Beads (100 l) were coated by
adding 30 g of either IgG1 (BD Biosciences) as control or
anti-HuR antibody 3A2 and incubated overnight at 4 °C. After
extensive washes of precoated Protein A–Sepharose beads, 100
l of precleared lysate was added and incubated for 4 h at 4 °C,
and then 30 g of proteinase K was added and incubated for 30
min at 55 °C to digest protein. RNA was extracted and reversetranscribed, and the presence of specific target mRNAs was
quantified by quantitative PCR analysis.
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